Company Encyclopedia
View More
name
Organigram
OGI.US
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers.
4.514 T
OGI.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Organigram to report Q4 fiscal 2025 results on Dec 16, 2025. #1 cannabis company in Canada by market share. Conference call at 8am ET.

    Organigram Global Inc., listed on NASDAQ (OGI) and TSX (OGI), Canada's top cannabis company by market share, is set to release its fourth-quarter fiscal 2025 earnings on Tuesday, December 16, 2025, before the market opens. A conference call to discuss the results will follow on the same day at 8:00 am Eastern Time. Investors and analysts can register for the call to obtain more details.

    Unusual Whales·
    US
    OGI
    -2.38%
    Unusual Whales·
    US
    OGI
    -2.38%

    Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 | OGI Stock News

    Organigram Global Inc. will report its fourth quarter fiscal 2025 results on December 16, 2025, before market open. The company will host a conference call to discuss the results. Organigram is a leading cannabis company in Canada, involved in both the US and Canadian cannabinoid beverages markets. The company operates multiple facilities across Canada and is regulated by the Cannabis Act and Regulations. The announcement includes forward-looking statements with associated risks and uncertainties.

    StockTitan·
    US
    OGI
    -2.38%
    StockTitan·
    US
    OGI
    -2.38%

    OrganiGram reports FY2024 net revenue of CAD 159.8 million, up 17.6 percent

    OrganiGram Global Inc. reported a 17.6% increase in net revenue to CAD 159.8 million for FY2024, with a 37% adjusted gross margin and CAD 5.9 million in adjusted EBITDA for Q4. The company also achieved CAD 8.9 million in cash flow from operations in Q4. Post-acquisition of Motif Labs, OrganiGram became Canada's largest cannabis company by market share. This information is AI-generated and not financial advice.

    Reuters·
    US
    OGI
    -2.38%
    Reuters·
    US
    OGI
    -2.38%

    OrganiGram Hires James Yamanaka as CEO

    06:29 AM EST, 11/25/2025 (MT Newswires) -- Organigram Global ( OGI ) said Tuesday that it has appointed James Yamanaka as chief executive officer, effective on or about Jan. 15.Yamanaka was most recently the global head of strategy for British American Tobacco, Organigram said.Organigram also said chairman Peter Amirault will serve as executive chair on an interim basis beginning Dec. 1 to oversee day-to-day operations until Yamanaka assumes the CEO role. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

    fidelity·
    US
    OGI
    -2.38%
    fidelity·
    US
    OGI
    -2.38%

    Organigram Announces Appointment Of Chief Executive Officer

    Nov 25 (Reuters) - Organigram Global Inc (OGI.TO) :* ORGANIGRAM ANNOUNCES APPOINTMENT OF CHIEF EXECUTIVE OFFICER* ORGANIGRAM GLOBAL - APPOINTS JAMES YAMANAKA AS CEO Source text: Further company coverage: (OGI.TO)

    Reuters·
    US
    OGI
    -2.38%
    Reuters·
    US
    OGI
    -2.38%
    © 2025 Longbridge｜Disclaimer